About this trial
The psychological challenges faced by patients with incurable cancer and their caregivers include an uncertain future, fear of dying and uncontrollable suffering, grief, and loneliness. In a significant subgroup, this challenge is associated with significant fear and existential distress. This distress can manifest itself, for example, in the form of demoralization, a state of despair and hopelessness in which the possibilities for coping seem exhausted. Although open discussions about fears at the end of life are becoming increasingly important, little is known about how patients with high existential distress can best be supported to promote quality of life.
The aim of the study is to test the effectiveness of the newly developed individual psychotherapy ORPHYS (ShORt-term psychodynamic psychotherapy in serious PHYSical illness) in reducing existential distress. To this end, a randomly selected half of the participants who receive ORPHYS treatment will be compared with a second group who receive the standard routine psycho-oncological treatment TAU (Treatment As Usual). The level of distress caused by demoralization will be used for the comparison. A total of 160 patients with advanced cancer will be included in the study.
Due to improved treatment options, life expectancy for advanced cancer has increased significantly. This means that patients and their families must deal with the existential tension between uncertainty and a focus on life. The treatment is intended to contribute to providing the best possible support for patients who suffer from uncertainty and fears at the end of life.
Eligibility criteria
Qualifiers
UICC stage III/IV solid tumor or advanced hematological cancer
Physical condition at beginning of treatment sufficient for outpatient treatment
Existential distress due to at least one of the following concerns: loss of hope, demoralization, fear of the future, loneliness, death anxiety, sense of isolation, death wishes
Severity of distress: significant subjective distress and impairment in functioning
Disqualifiers
Acute suicidality with concrete or impending intent to follow through (suicide plan)
diagnosis of a substance dependence, substance abuse, or psychotic disorder (exception: tobacco-related disorders)
Inability to adhere to a psychotherapeutic setting
Other current psychotherapeutic or psycho-oncological treatment according to TAU definition
Trial design
Treatments tested in this trial
- ORPHYS (ShORt-term psychodynamic psychotherapy in serious PHYSical illness)
- TAU (Treatment As Usual: Standard psycho-oncological care)
Treatment groups
Sponsors and collaborators
Universitätsklinikum Hamburg-Eppendorf
Lead sponsor
University Düsseldorf
Collaborator
Wuerzburg University Hospital
Collaborator
University of Kassel
Collaborator